In order to provide you with relevant and meaningful content we need to know more about you.
Please choose the category that best describes you.
This content is intended for U.S. Healthcare Professionals. Would you like to proceed?
If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.
See full prescribing information for complete boxed warning.
Sufentanil Citrate Injection exposes users...
Sufentanil Citrate Injection is indicated for intravenous administration in adults and pediatric patients:
Sufentanil Citrate Injection should be administered only by persons specifically...
Sufentanil Citrate Injection, USP 50 mcg/mL (equivalent to 50 mcg/mL sufentanil base).
Sufentanil Citrate Injection is contraindicated in patients with:
Sufentanil Citrate Injection contains sufentanil, a Schedule II controlled substance. As an opioid,...
The following serious adverse reactions are described, or described in greater detail, in other sections:
Table 3 includes clinically significant drug interactions with Sufentanil Citrate Injection.
Prolonged use of opioid...
Sufentanil Citrate Injection contains sufentanil, a Schedule II controlled substance.
Acute overdose with Sufentanil Citrate Injection can be manifested by respiratory depression,...
Sufentanil Citrate Injection, USP is a sterile, nonpyrogenic solution of sufentanil citrate in water for injection. Sufentanil Citrate is a potent opioid analgesic which is administered either epidurally or by...
Sufentanil is an opioid agonist. When used in balanced general anesthesia, sufentanil has been reported to be as...
Epidural Use in Labor and Delivery
Epidural sufentanil was tested in 340 patients in two (one single-center and one...
Sufentanil Citrate Injection, USP equivalent to 50 mcg/mL sufentanil is supplied in the following single-dose containers:
Distributed by Hospira, Inc., Lake Forest, IL 60045 USA
Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine.
*Contact Medical Information. 9AM-5PM ET Monday to Friday; excluding holidays.
Submit a medical question for Pfizer prescription products.
To report an adverse event related to the Pfizer-BioNTech COVID-19 Vaccine, and you are not part of a clinical trial* for this product, click the link below to submit your information:
Pfizer Safety Reporting Site
*If you are involved in a clinical trial for this product, adverse events should be reported to your coordinating study site.
If you cannot use the above website, or would like to report an adverse event related to a different Pfizer product, please call Pfizer Safety at (800) 438-1985.
You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at https://vaers.hhs.gov or call (800) 822-7967.